A clinical trial, partly based at the University of Virginia Center for Diabetes Technology, has shown that an artificial pancreas, consisting of a continuous glucose monitor (such as the Dexcom G6) coupled with an insulin pump, can more effectively control blood glucose levels in patients with type 1 diabetes than conventional treatments. The (Read more...)